Alexion’s Camilla Harder Hartvig on making the impossible possible in rare diseaseAlexion’s senior vice president of its international business talks to Paul Tunnah about the importance of “people-centred and Share XAlexion’s Camilla Harder Hartvig on making the impossible possible in rare diseasehttps://pharmaphorum.com/views-and-analysis/alexions-camilla-harder-hartvig-on-rare-diseases/
Health Innovators: Owlstone Medical’s Billy Boyle on breath biopsy technologyIn the latest episode of our Health Innovators series, Paul Tunnah speaks to Billy Boyle, co-founder and CEO Share XHealth Innovators: Owlstone Medical’s Billy Boyle on breath biopsy technologyhttps://pharmaphorum.com/video/health-innovators-billy-boyle-owlstone-medical/
Health Innovators: Sergey Young on how technology can extend human lifeHow can humans extend their life span? In the second episode of our Health Innovators series, Paul Tunnah Share XHealth Innovators: Sergey Young on how technology can extend human lifehttps://pharmaphorum.com/digital/health-innovators-sergey-young-on-how-technology-can-extend-human-life/
The calm after the storm: How COVID-19 is making pharma more resilientCOVID-19 is proving to be the perfect storm in terms of the supply of pharmaceutical products. But learning Share XThe calm after the storm: How COVID-19 is making pharma more resilienthttps://pharmaphorum.com/views-analysis-sales-marketing/the-calm-after-the-storm-how-covid19-is-making-pharma-more-resilient-and-accessible/
Vertex Pharma’s vision for reimbursement innovationAs regional vice president for Northern Europe & Australia, Simon Lem led the digital launch of Vertex Pharma’s Share XVertex Pharma’s vision for reimbursement innovationhttps://pharmaphorum.com/views-analysis-market-access/vertex-pharmas-vision-for-reimbursement-innovation/
Alnylam’s Anant Murthy on making it as a US biotech in EuropeAlnylam’s European head of market access and GM of mid-size markets, Anant Murthy, shares his perspective on how Share XAlnylam’s Anant Murthy on making it as a US biotech in Europehttps://pharmaphorum.com/r-d/views-analysis-r-d/alnylam-anant-murthy-on-making-it-as-a-us-biotech-in-europe/
When healthcare met digital health: the next chapter of pharmaphorumBack in 2009, when I was living in Windsor, I remember walking to the pub with my wife Share XWhen healthcare met digital health: the next chapter of pharmaphorumhttps://pharmaphorum.com/views-analysis-digital/when-healthcare-met-digital-health-the-next-chapter-of-pharmaphorum/
Janssen’s Gaëtan Leblay on leading during the COVID-19 crisisCOVID-19 is putting unimaginable pressure on healthcare systems and the companies looking for solutions to end the pandemic. Share XJanssen’s Gaëtan Leblay on leading during the COVID-19 crisishttps://pharmaphorum.com/r-d/views-analysis-r-d/janssens-gaetan-leblay-on-leading-during-the-covid-19-crisis/
Has COVID-19 forever changed the way pharma does business?There’s no doubt that the COVID-19 pandemic has thrust digital engagement into the spotlight for the pharmaceutical industry Share XHas COVID-19 forever changed the way pharma does business?https://pharmaphorum.com/views-and-analysis/has-covid-19-forever-changed-the-way-pharma-does-business/
